<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02425254</url>
  </required_header>
  <id_info>
    <org_study_id>15029</org_study_id>
    <nct_id>NCT02425254</nct_id>
  </id_info>
  <brief_title>Preemptive Paracetamol for Postoperative Pain</brief_title>
  <acronym>PPPP</acronym>
  <official_title>Preemptive Paracetamol for Postoperative Pain: a Randomised, Double-blind, Two Way Crossover Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nottingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nottingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test whether a dose of paracetamol given before surgical
      incision is more effective at reducing postoperative pain and analgesic consumption in
      cervical spine surgery versus a dose given at the end of surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morphine consumption</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Measured from PCA machine</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first analgesic request</measure>
    <time_frame>24 hours</time_frame>
    <description>In minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea and vomiting</measure>
    <time_frame>24 hours</time_frame>
    <description>Incidence of nausea or vomiting 24 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pruritus</measure>
    <time_frame>24 hours</time_frame>
    <description>Incidence of pruritus 24 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation</measure>
    <time_frame>24 hours</time_frame>
    <description>Incidence of sedation 24 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary retention</measure>
    <time_frame>24 hours</time_frame>
    <description>Incidence of urinary retention 24 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Allergic reaction</measure>
    <time_frame>24 hours</time_frame>
    <description>Incidence of allergic reaction (defined as diagnosed by clinician 24 hours postoperatively)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>1 hour</time_frame>
    <description>Numeric rating scale (NRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>2 hours</time_frame>
    <description>Numeric rating scale (NRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>6 hours</time_frame>
    <description>Numeric rating scale (NRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>12 hours</time_frame>
    <description>Numeric rating scale (NRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>24 hours</time_frame>
    <description>Numeric rating scale (NRS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pain</condition>
  <condition>Surgical Wound</condition>
  <arm_group>
    <arm_group_label>Preemptive paracetamol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1000mg intravenous paracetamol given ≥15 minutes before surgical incision and intravenous saline 15 minutes before the end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Postincision paracetamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous saline ≥15 minutes before surgical incision and 1000mg intravenous paracetamol given 15 minutes before the end of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous paracetamol</intervention_name>
    <description>1000mg intravenous solution for infusion</description>
    <arm_group_label>Preemptive paracetamol</arm_group_label>
    <arm_group_label>Postincision paracetamol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous saline 0.9%</intervention_name>
    <description>0.9% sodium chloride in order to ensure double-blinding</description>
    <arm_group_label>Preemptive paracetamol</arm_group_label>
    <arm_group_label>Postincision paracetamol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18-80 years old

          -  Patients listed for non-malignant cervical spinal surgery

          -  General anaesthesia

          -  Capacity to give informed consent

          -  Ability to use PCA device and pain score scale

          -  ASA I, II and III

          -  &gt;50kg in weight

        Exclusion Criteria:

          -  Allergy or sensitivity to paracetamol, proparacetamol or morphine

          -  Liver disease

          -  Renal disease (creatinine clearance &lt;30ml/min)

          -  Bleeding disorder

          -  Chronic alcoholism

          -  Chronic malnutrition

          -  Dehydration

          -  G6PD deficiency

          -  Hypernatraemia (Na &gt;150)

          -  Hypokalaemia (K &lt;3.5) and hyperchloraemia

          -  Pregnancy or breast-feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Williams</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nottiongham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John Williams, PhD</last_name>
    <phone>01332 724641</phone>
    <email>john.williams7@nottingham.ac.uk</email>
  </overall_contact>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2015</study_first_submitted>
  <study_first_submitted_qc>April 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2015</study_first_posted>
  <last_update_submitted>December 2, 2015</last_update_submitted>
  <last_update_submitted_qc>December 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

